SCHEMBL6920296

SCHEMBL6920296

COc1c(Nc2ccc(C#N)cc2)nc(C2=CCCC=C2)nc1-c1ccc(C)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ABCG2 Q9UNQ0 3/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
KDM4E B2RXH2 1/20 0.35
DHODH Q02127 2/20 0.35
KDM1A O60341 1/20 0.35
THRB P10828 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
MAPKAPK2 P49137 1/20 0.34
GSK3B P49841 2/20 0.34
CDK1 P06493 1/20 0.34
KDR P35968 1/20 0.34
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
F9 P00740 1/20 0.33
CSNK1A1 P48729 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6919662 0.81 ABCG2 (0.55) ABCG2ADORA2AADORA1KDM4EKDM1A
SCHEMBL1232774 0.73 F9 (0.53) MEN1KMT2AABCG2KDM4EDHODH
SCHEMBL21982029 0.67 ABCG2 (0.62) ABCG2
SCHEMBL6919145 0.67 F9 (0.42) MEN1KMT2AABCG2ADORA2AADORA1
SCHEMBL1231102 0.66 ABCG2 (0.57) MEN1KMT2AABCG2ADORA2AADORA1
SCHEMBL9607749 0.66 ABCG2 (0.50) MEN1KMT2AABCG2KDM4EKDM1A
SCHEMBL29165766 0.65 MMP3 (0.41) CA12CA1CA2CA9PTGS2
SCHEMBL6919146 0.64 KDM4E (0.44) MEN1KMT2AABCG2ADORA2AADORA1
SCHEMBL21728479 0.62 L3MBTL1 (0.44) MEN1KMT2AABCG2ADORA2AADORA1
SCHEMBL23020098 0.62 ADORA1 (0.34) MEN1KMT2AABCG2ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011017296-A1 4, 5, 6-TRISUBSTITUTED PYRIMIDINE DERIVATIVES AS FACTOR IXA INHIBITORS SCHERING CORPORATION (US) 2011-02-10 WO disclosed